OH2 Administered by Intratumoral Injection
NCT05954091
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
OH2 Injection
Sponsor
Binhui Biopharmaceutical Co., Ltd.